A large cohort of patients around the world diagnosed with myelofibrosis (aka bone marrow cancer) will soon be able to…
There is an urgent need for better treatment for myelodysplastic syndrome (MDS), a type of blood cancer, and new research…
As a medical research company, successful trial outcomes are a must but business acumen in understanding the market is no…
Aussies are some of the most enthusiastic adopters of new clinical drugs. In 2019, 95,000 of us participated in nearly…
Having delivered impressive interim trial data from their Phase 2 clinical trials for a treatment targeting incurable bone marrow cancer,…
When it comes to biotech investing, the value opportunities in Australia attract many of the world's smartest investors. Amongst them,…